Position in AZN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,138,990,531
New position
Shares Held
10,845,708
first reported quarter
Ownership
0.699%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 87.2443182132508.ToString("F0")%
Shared 0.ToString("F0")%
None 12.755681786749193.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Fisher Asset Management, LLC holds $22,494,530,611 across 14 Drug Manufacturers - General names. AZN ranks #5 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,838,986 | $4,450,754,153 | |
| 2 | MRK |
Merck & Co., Inc.
|
26,436,284 | $3,180,020,602 | |
| 3 | PFE |
Pfizer Inc
|
104,964,427 | $2,947,401,110 | |
| 4 | JNJ |
Johnson & Johnson
|
9,263,611 | $2,264,397,072 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
10,845,708 | $2,138,990,531 | |
| 6 | NVS |
Novartis AG
|
13,885,749 | $2,121,048,159 | |
| 7 | ABBV |
AbbVie Inc.
|
9,092,054 | $1,977,430,824 | |
| 8 | GSK |
GSK plc
|
34,522,363 | $1,905,289,213 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,138,990,531 | 10,845,708 | Shares | Defined | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||